Pharsight

Nizoral Anti-dandruff patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5456851 KRAMER Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole
Apr, 2014

(10 years ago)

Nizoral Anti-Dandruff is owned by Kramer.

Nizoral Anti-Dandruff contains Ketoconazole.

Nizoral Anti-Dandruff has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Nizoral Anti-Dandruff are:

  • US5456851

Nizoral Anti-Dandruff was authorised for market use on 10 October, 1997.

Nizoral Anti-Dandruff is available in shampoo;topical dosage forms.

The generics of Nizoral Anti-Dandruff are possible to be released after 07 April, 2014.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using KETOCONAZOLE ingredient

Market Authorisation Date: 10 October, 1997

Treatment: NA

Dosage: SHAMPOO;TOPICAL

More Information on Dosage

NIZORAL ANTI-DANDRUFF family patents

Family Patents